DOCK8, a member of the dedicator of cytokinesis (DOCK) family of guanine nucleotide exchange factors (GEFs), plays a crucial role in regulating various cellular processes, particularly those related to the cytoskeleton dynamics and immune function. Specifically, DOCK8 functions as a key modulator of actin cytoskeletal rearrangements, which are essential for processes such as cell migration, adhesion, and immune cell activation. Moreover, DOCK8 is prominently expressed in hematopoietic cells, where it exerts its regulatory influence on immune cell function and responses. Notably, mutations in the DOCK8 gene have been associated with severe combined immunodeficiency (SCID) and hyper-IgE syndrome (HIES), underscoring its significance in immune system homeostasis and function.
Activation of DOCK8 involves intricate signaling cascades and regulatory mechanisms that converge to modulate its GEF activity and subsequent downstream effects on cytoskeletal dynamics and immune cell function. One major mechanism of DOCK8 activation involves its interaction with various upstream signaling molecules, including small GTPases of the Rho family such as Rac1 and Cdc42. Upon stimulation by extracellular cues such as growth factors or immune cell receptor engagement, these small GTPases undergo activation and transduce signals to DOCK8, promoting its recruitment to specific cellular locations. Additionally, post-translational modifications such as phosphorylation and ubiquitination have been implicated in regulating DOCK8 activity, further fine-tuning its functional outcomes. Furthermore, DOCK8 activation is intricately linked to cellular processes such as receptor-mediated signaling and cytoskeletal rearrangements, highlighting its multifaceted role in coordinating immune responses and cellular functions. Overall, elucidating the mechanisms of DOCK8 activation provides valuable insights into its physiological functions and its contribution to immune system regulation and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) and is known to stimulate various signaling pathways, including the MAPK pathway. Activation of PKC can indirectly influence DOCK 8 by modulating downstream targets that intersect with DOCK 8-associated pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of intracellular cAMP. Elevated cAMP levels can activate protein kinase A (PKA), which may impact DOCK 8 indirectly through cAMP/PKA-mediated signaling cascades. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces endoplasmic reticulum (ER) stress by inhibiting sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). ER stress can activate the unfolded protein response (UPR), which may indirectly influence DOCK 8 signaling through cross-talk between UPR and related pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB modulates intracellular calcium levels by targeting inositol trisphosphate receptors (IP3Rs). Changes in intracellular calcium levels can impact various signaling cascades, potentially influencing DOCK 8 signaling through calcium-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. Elevated calcium levels can activate various calcium-dependent signaling pathways, which may indirectly influence DOCK 8 signaling through cross-talk between calcium-related pathways. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic Acid has been reported to activate AMP-activated protein kinase (AMPK). Activation of AMPK can influence cellular energy metabolism and may indirectly affect DOCK 8 signaling through AMPK-related metabolic pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, Calyculin A can indirectly affect DOCK 8 signaling, as phosphorylation events regulated by these phosphatases intersect with DOCK 8-associated pathways. | ||||||